Prof. Dr. Berna AKINCI ÖZYÜREK

1. Reassessment of risk profiles through weight and BMI changes in idiopathic pulmonary fibrosis

BOZKUŞ F., Deniz P. P., ÜZER F., Yazıcı O., Dikiş Ö. Ş., Tapan U., et al.

Heart and Lung , cilt.79, 2026 (SCI-Expanded, Scopus)

2. Pulmonary Alveolar Proteinosis in Greece–Türkiye–Cyprus: Answers in a Real-Life Comparison

Papiris S. A., UĞUR CHOUSEIN E. G., Kallieri M., Mogulkoc N., Papaioannou A. I., Frangopoulos F., et al.

Respirology , 2026 (SCI-Expanded, Scopus)

3. CONUT score as a prognostic biomarker in progressive pulmonary fibrosis: a simple tool for clinical risk stratification

Akkurt E. S., Sahin Ozdemirel T., AKINCI ÖZYÜREK B., Ensarioglu K., Duvenci Birben O., Zenbilli E.

BMC Pulmonary Medicine , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

4. Fibrotic Patterns and Diagnostic Correlates in Hypersensitivity Pneumonitis: Clinical, Radiologic, and Hematologic Insights

Akkurt E. S., AKINCI ÖZYÜREK B., Ensarioglu K., Sahin Ozdemirel T., Duvenci Birben O., ERTÜRK H., et al.

Diagnostics , cilt.15, sa.24, 2025 (SCI-Expanded, Scopus)

5. Evaluation of patients diagnosed with primary Sjogren’s syndrome with and without pulmonary involvement

Ozsoy Z., Ozdemırel T. Ş., Ensarıoğlu K., ERTÜRK H., ÖZTÜRK Z., Yıldırım H., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , cilt.42, sa.3, 2025 (SCI-Expanded, Scopus)

6. Is pulmonary Langerhans cell histiocytosis really rare?: A retrospective cohort study

Akkurt E. S., AKINCI ÖZYÜREK B., Ensarioglu K., Sahin Ozdemirel T., Zenbilli E., ERTÜRK H.

Medicine (United States) , cilt.104, sa.32, 2025 (SCI-Expanded, Scopus)

7. Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis

ÖCAL N., ÇİLLİ A., Mogulkoc N., COŞKUN N. F., URSAVAŞ A., HANTA İ., et al.

Annals of Thoracic Medicine , cilt.20, sa.2, ss.98-107, 2025 (SCI-Expanded, Scopus)

8. Antifibrotic treatment response comparison of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis

AKINCI ÖZYÜREK B., Ensarioğlu K., Özdemirel T. Ş., Akkurt E. S., Özdağ Ö., Zenbilli E.

Turkish Journal of Medical Sciences , cilt.54, sa.5, ss.900-907, 2024 (SCI-Expanded, Scopus, TRDizin)

9. Relation between carotid intima-media thickness, serum paraoxonase levels and severity of obstructive sleep apnea syndrome

Akkurt E. S., Bozbas S. S., Eroglu S., Ozcalik E., Ozer E. O., AKINCI ÖZYÜREK B., et al.

Bratislava Medical Journal , cilt.124, sa.12, ss.886-891, 2023 (SCI-Expanded, Scopus)

10. Does cryptogenic organizing pneumonia change seasonal?

Ozdemirel T. S., BULUT S., Akkurt E. S., Ozen Z. E., Erdogdu M. H., DEMİRAĞ F., et al.

Revista da Associacao Medica Brasileira , cilt.69, sa.2, ss.267-271, 2023 (SCI-Expanded, Scopus)

11. Factors associated with mortality in cases of idiopathic pulmonary fibrosis with mild to moderate functional impairment

Şengül A., AKINCI ÖZYÜREK B., COŞKUN N. F., Yazıcı O., BOZKUŞ F., Yıldız Gülhan P., et al.

Eurasian Journal of Pulmonology , cilt.25, sa.3, ss.166-173, 2023 (ESCI, Scopus, TRDizin)

12. Comparison of clinical characteristics in adult patients under 65 years of age with and without Covid-19 pneumonia

Ozdemirel T. S., Akkurt E. S., Ertan O., GÖKLER M. E., AKINCI ÖZYÜREK B.

Lung India , cilt.39, sa.5, ss.422-427, 2022 (ESCI, Scopus)

13. The use of ezpap in patients with Covid-19 pneumonia and multiple sclerosis

Akkurt E. S., Sahin Ozdemirel T., Ertan O., AKINCI ÖZYÜREK B.

Journal of Experimental and Clinical Medicine (Turkey) , cilt.39, sa.2, ss.551-553, 2022 (Scopus)

14. What are the factors that affect post COVID 1st month's continuing symptoms?

AKINCI ÖZYÜREK B., Sahin Ozdemirel T., Akkurt E. S., YENİBERTİZ D., Saymaz Z. T., Büyükyaylacı Özden S., et al.

International Journal of Clinical Practice , cilt.75, sa.11, 2021 (SCI-Expanded, Scopus)

15. The evaluation of lung involvement and functional capacities in patients diagnosed with primary Sjogren’s syndrome

Sahin Ozdemirel T., Ozdemirel A. E., AKINCI ÖZYÜREK B., YENİBERTİZ D., ERDOĞAN Y.

International Journal of Clinical Practice , cilt.75, sa.10, 2021 (SCI-Expanded, Scopus)

16. Effect of Asbestos Exposure on the Frequency of EGFR Mutations and ALK/ROS1 Rearrangements in Patients With Lung Adenocarcinoma: A Multicentric Study

YILMAZ Ş., YILMAZ DEMİRCİ N., METİNTAŞ S., Zamani A., Karadag M., AYDIN GÜÇLÜ Ö., et al.

Journal of Occupational and Environmental Medicine , cilt.63, sa.3, ss.238-243, 2021 (SCI-Expanded, Scopus)

17. A rare case: Pulmonary thromboembolism and pneumothorax coexistence secondary to Covid-19 infection

Ertan Ö., Akkurt E. S., Şahin Özdemirel T., DEMİRÖZ Ş. M., AKINCI ÖZYÜREK B.

Journal of Experimental and Clinical Medicine (Turkey) , cilt.38, sa.4, ss.689-692, 2021 (Scopus)

18. What are the predictors of delirium for patients with lung cancer?

YENİBERTİZ D., Aydin M. S., AKINCI ÖZYÜREK B.

Turk Hijyen ve Deneysel Biyoloji Dergisi , cilt.78, sa.1, ss.31-38, 2021 (Scopus, TRDizin)

19. A rare case: Covid-19 infection diagnosed by transthoracic fine needle aspiration biopsy

Şahi̇n Özdemi̇Rel T., Akkurt E. S., Ertan Ö., Nomenoğlu H., Kaya S., AKINCI ÖZYÜREK B.

Journal of Experimental and Clinical Medicine (Turkey) , cilt.38, sa.4, ss.682-684, 2021 (Scopus)

20. Evaluation of changes in the smoking habits of patients with coronavirus disease-19

YENİBERTİZ D., AKINCI ÖZYÜREK B., Şengezer T., Gökler E., Dığrak G. S., Koç F.

Eastern Journal of Medicine , cilt.26, sa.1, ss.145-150, 2021 (Scopus, TRDizin)

21. Is Onodera’s prognostic nutritional index (OPNI) a prognostic factor in small cell lung cancer (SCLC)?

YENİBERTİZ D., AKINCI ÖZYÜREK B., Erdogan Y.

Clinical Respiratory Journal , cilt.14, sa.8, ss.689-694, 2020 (SCI-Expanded, Scopus)

22. Sleep disturbances in patients with lung cancer in Turkey Türkiye’de akciğer kanseri hastalarında uyku bozuklukları

BÜLBÜL Y., Özlü T., ARINÇ S., AKINCI ÖZYÜREK B., Günbatar H., Şentürk A., et al.

Tuberkuloz ve Toraks , cilt.66, sa.4, ss.297-303, 2018 (Scopus, TRDizin)

23. Assessment of Palliative Care in Lung Cancer in Turkey

BÜLBÜL Y., Ozlu T., ARINÇ S., AKINCI ÖZYÜREK B., Günbatar H., Senturk A., et al.

Medical Principles and Practice , cilt.26, sa.1, ss.50-56, 2017 (SCI-Expanded, Scopus)

Prof. Dr. Berna AKINCI ÖZYÜREK

Yayınlar & Eserler

1. Reassessment of risk profiles through weight and BMI changes in idiopathic pulmonary fibrosis

2. Pulmonary Alveolar Proteinosis in Greece–Türkiye–Cyprus: Answers in a Real-Life Comparison

3. CONUT score as a prognostic biomarker in progressive pulmonary fibrosis: a simple tool for clinical risk stratification

4. Fibrotic Patterns and Diagnostic Correlates in Hypersensitivity Pneumonitis: Clinical, Radiologic, and Hematologic Insights

5. Evaluation of patients diagnosed with primary Sjogren’s syndrome with and without pulmonary involvement

6. Is pulmonary Langerhans cell histiocytosis really rare?: A retrospective cohort study

7. Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis

8. Antifibrotic treatment response comparison of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis

9. Relation between carotid intima-media thickness, serum paraoxonase levels and severity of obstructive sleep apnea syndrome

10. Does cryptogenic organizing pneumonia change seasonal?

11. Factors associated with mortality in cases of idiopathic pulmonary fibrosis with mild to moderate functional impairment

12. Comparison of clinical characteristics in adult patients under 65 years of age with and without Covid-19 pneumonia

13. The use of ezpap in patients with Covid-19 pneumonia and multiple sclerosis

14. What are the factors that affect post COVID 1st month's continuing symptoms?

15. The evaluation of lung involvement and functional capacities in patients diagnosed with primary Sjogren’s syndrome

16. Effect of Asbestos Exposure on the Frequency of EGFR Mutations and ALK/ROS1 Rearrangements in Patients With Lung Adenocarcinoma: A Multicentric Study

17. A rare case: Pulmonary thromboembolism and pneumothorax coexistence secondary to Covid-19 infection

18. What are the predictors of delirium for patients with lung cancer?

19. A rare case: Covid-19 infection diagnosed by transthoracic fine needle aspiration biopsy

20. Evaluation of changes in the smoking habits of patients with coronavirus disease-19

21. Is Onodera’s prognostic nutritional index (OPNI) a prognostic factor in small cell lung cancer (SCLC)?

22. Sleep disturbances in patients with lung cancer in Turkey Türkiye’de akciğer kanseri hastalarında uyku bozuklukları

23. Assessment of Palliative Care in Lung Cancer in Turkey

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim